OncLive | Bringing the Global Oncology Community Together

OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

OncLive Global Expo

Giants of Cancer Care

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

Latest News

OncLive to Induct the 2019 Class of Giants of Cancer Care

OncLive to Induct the 2019 Class of Giants of Cancer Care

OncLive^® is proud to announce the inductees of the 2019 Giants of Cancer Care^® recognition program. Read More >>

OncFellows Forum

Role of Liquid Biopsies Still Needs Refining in Breast Cancer

Chemoimmunotherapy Emerges as Frontline Standard in Squamous NSCLC

Tagraxofusp Elicits Responses in Treatment-Naive and Relapsed BPDCN

Focus in Oncogene-Driven NSCLC Turns to Sequencing Strategies, Overcoming Resistance

Clinical Outcomes Consistent in MCL Irrespective of Induction Regimen

View More Stories >>

top border

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Wisconsin

2019 European Lung Cancer Congress

2019 NCCN Annual Conference

2019 State of the Science Summit on Hematologic Malignancies

2019 SGO Annual Meeting

Dr. Mullighan on Germline Predisposition to ALL

Dr. Mullighan on Germline Predisposition to ALL

Dr. O'Hara on the Rationale for APX005M in Combination With Chemotherapy and Nivolumab in Pancreatic Cancer

Dr. O'Hara on the Rationale for APX005M in Combination With Chemotherapy and Nivolumab in Pancreatic Cancer

Dr. Tolaney on Presence of PIK3CA and ESR1 Mutations in MONARCH 2 Trial in Breast Cancer

Dr. Tolaney on Presence of PIK3CA and ESR1 Mutations in MONARCH 2 Trial in Breast Cancer

Dr. Reimuth Discusses Studies Looking at Resistance to EGFR TKIs in NSCLC

Dr. Mok Discusses Updated Data With Pembrolizumab in NSCLC

Dr. Garassino Discusses PROs With Durvalumab by PD-L1 Expression in Stage III NSCLC

Dr. Binder on Data Regarding Rucaparib Maintenance in Pancreatic Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Goals in Previously Treated Advanced Renal Cell Carcinoma

Goals in Previously Treated Advanced Renal Cell Carcinoma

Precision Medicine in Solid Tumor Malignancies

Precision Medicine in Solid Tumor Malignancies

Selecting an Optimal Second-Line Regimen for mRCC

Selecting an Optimal Second-Line Regimen for mRCC

Frontline Therapy for mRCC: Sequencing and Goals

Evaluating I-O Monotherapy's Value in Treating mRCC

mRCC: Identifying and Managing AEs in TKIs and IO Therapy

CDK4/6 Inhibitors: Treating Beyond Progression

OncLive houses thousands of videos that provide updates and information.
See more Videos

ADT and the Need for a Multidisciplinary Approach

ADT and the Need for a Multidisciplinary Approach

Optimizing Prevention of MACEs in Prostate Cancer

Optimizing Prevention of MACEs in Prostate Cancer

Standard of Care in Metastatic Prostate Cancer

Standard of Care in Metastatic Prostate Cancer

Real-World Patients With High Risk of MACEs

GnRH Antagonists Versus GnRH Agonists

Effects of ADT on Morbidity and Mortality

Data Supporting the Risk of MACEs in ADT

OncLive houses thousands of videos that provide updates and information.
See more Videos

top border

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Fakih Discusses the Utility of Immunoscore in CRC

Marwan Fakih, MD, of City of Hope, discusses the clinical utility of the Immunoscore in patients with colorectal cancer.

View more >>>

Featured Video

Novel Combination Approaches for Metastatic Kidney Cancer

Novel Combination Approaches for Metastatic Kidney Cancer

Brian Rini, MD, and David F. McDermott, MD, discuss novel combination approaches for patients with metastatic renal cell carcinoma. View now

FDA Approvals in Bladder Cancer and NSCLC, and 2019 ELCC Highlights

Gina Columbus

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

OncLive State of the Science Summit

OncLive SAP

OncLive^® On Air is a podcast of interviews with academic oncologists on their presentations from the OncLive^® State of the Science Summits^TM.

Trending Now

Dr. O'Hara on the Rationale for APX005M in Combination With Chemotherapy and Nivolumab in Pancreatic Cancer

Role of Liquid Biopsies Still Needs Refining in Breast Cancer

Dr. Garassino Discusses PROs With Durvalumab by PD-L1 Expression in Stage III NSCLC

SM-88 May Fill Unmet Need in Pancreatic Cancer

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

Dermatologists in Cancer Care®

Milestones In Medicine

Rapid Reviews in Oncology®

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.

x